CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands |
Total |
Series C Preferred Stock |
Common stock |
Additional paid-in capital |
Accumulated other comprehensive income (loss) |
Accumulated deficit |
Accumulated deficit
Series C Preferred Stock
|
Treasury stock |
Non - controlling interests |
| Beginning balance (in shares) at Dec. 31, 2022 |
|
|
42,344,827
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2022 |
$ (28,208)
|
|
$ 423
|
$ 122,633
|
$ 73
|
$ (171,757)
|
|
$ (16)
|
$ 20,436
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Share-based compensation from issuance of options and compensation-based warrants |
613
|
|
|
613
|
|
|
|
|
|
| Exercise of stock options (in shares) |
|
|
5,200
|
|
|
|
|
|
|
| Exercise of stock options |
5
|
|
|
5
|
|
|
|
|
|
| Accretion of 15.00% Series C preferred shares |
(8,879)
|
|
|
(8,879)
|
|
|
|
|
|
| Issuance of warrants |
8,607
|
|
|
8,607
|
|
|
|
|
|
| Foreign currency translation adjustment |
11
|
|
|
|
11
|
|
|
|
|
| Net income (loss) |
(24,643)
|
|
|
|
|
(24,643)
|
|
|
|
| Ending balance (in shares) at Mar. 31, 2023 |
|
|
42,350,027
|
|
|
|
|
|
|
| Ending balance at Mar. 31, 2023 |
(52,494)
|
|
$ 423
|
122,979
|
84
|
(196,400)
|
|
(16)
|
20,436
|
| Beginning balance (in shares) at Dec. 31, 2022 |
|
|
42,344,827
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2022 |
(28,208)
|
|
$ 423
|
122,633
|
73
|
(171,757)
|
|
(16)
|
20,436
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Net income (loss) |
(59,955)
|
|
|
|
|
|
|
|
|
| Ending balance (in shares) at Sep. 30, 2023 |
|
|
49,982,345
|
|
|
|
|
|
|
| Ending balance at Sep. 30, 2023 |
(95,880)
|
|
$ 500
|
115,676
|
(780)
|
(231,712)
|
|
0
|
20,436
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Temporary equity, shares percentage (as a percent) |
|
15.00%
|
|
|
|
|
|
|
|
| Beginning balance (in shares) at Mar. 31, 2023 |
|
|
42,350,027
|
|
|
|
|
|
|
| Beginning balance at Mar. 31, 2023 |
(52,494)
|
|
$ 423
|
122,979
|
84
|
(196,400)
|
|
(16)
|
20,436
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Share-based compensation from issuance of options and compensation-based warrants |
736
|
|
|
736
|
|
|
|
|
|
| Exercise of stock options (in shares) |
|
|
50,000
|
|
|
|
|
|
|
| Exercise of stock options |
5
|
|
$ 1
|
4
|
|
|
|
|
|
| Accretion of 15.00% Series C preferred shares |
(11,853)
|
|
|
(11,853)
|
|
|
|
|
|
| Issuance of warrants |
9,882
|
|
|
9,882
|
|
|
|
|
|
| Foreign currency translation adjustment |
(25)
|
|
|
|
(25)
|
|
|
|
|
| Net income (loss) |
(20,446)
|
|
|
|
|
(20,446)
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2023 |
|
|
42,400,027
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2023 |
(74,195)
|
|
$ 424
|
121,748
|
59
|
(216,846)
|
|
(16)
|
20,436
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Temporary equity, shares percentage (as a percent) |
|
15.00%
|
|
|
|
|
|
|
|
| Share-based compensation from issuance of options and compensation-based warrants |
715
|
|
|
715
|
|
|
|
|
|
| Conversion of note payable to common shares (in shares) |
|
|
7,582,318
|
|
|
|
|
|
|
| Conversion of note payable to common shares |
1,168
|
|
$ 76
|
1,076
|
|
|
|
16
|
|
| Accretion of 15.00% Series C preferred shares |
(11,502)
|
|
|
(11,502)
|
|
|
|
|
|
| Issuance of warrants |
3,639
|
|
|
3,639
|
|
|
|
|
|
| Foreign currency translation adjustment |
(839)
|
|
|
|
(839)
|
|
|
|
|
| Net income (loss) |
(14,866)
|
|
|
|
|
(14,866)
|
|
|
|
| Ending balance (in shares) at Sep. 30, 2023 |
|
|
49,982,345
|
|
|
|
|
|
|
| Ending balance at Sep. 30, 2023 |
(95,880)
|
|
$ 500
|
115,676
|
(780)
|
(231,712)
|
|
0
|
20,436
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Temporary equity, shares percentage (as a percent) |
|
15.00%
|
|
|
|
|
|
|
|
| Temporary equity, shares percentage (as a percent) |
|
15.00%
|
|
|
|
|
|
|
|
| Beginning balance (in shares) at Dec. 31, 2023 |
|
|
49,999,345
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2023 |
(129,184)
|
|
$ 500
|
111,982
|
(411)
|
(261,691)
|
|
0
|
20,436
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Share-based compensation from issuance of options and compensation-based warrants |
536
|
|
|
536
|
|
|
|
|
|
| Exercise of stock options (in shares) |
|
|
182,888
|
|
|
|
|
|
|
| Exercise of stock options |
2
|
|
|
2
|
|
|
|
|
|
| Accretion of 15.00% Series C preferred shares |
(13,781)
|
|
|
(13,781)
|
|
|
|
|
|
| Issuance of warrants |
7,392
|
|
|
7,392
|
|
|
|
|
|
| Foreign currency translation adjustment |
(203)
|
|
|
|
(203)
|
|
|
|
|
| Net income (loss) |
(27,954)
|
|
|
|
|
(27,954)
|
|
|
|
| Ending balance (in shares) at Mar. 31, 2024 |
|
|
50,182,233
|
|
|
|
|
|
|
| Ending balance at Mar. 31, 2024 |
(163,192)
|
|
$ 500
|
106,131
|
(614)
|
(289,645)
|
|
0
|
20,436
|
| Beginning balance (in shares) at Dec. 31, 2023 |
|
|
49,999,345
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2023 |
(129,184)
|
|
$ 500
|
111,982
|
(411)
|
(261,691)
|
|
0
|
20,436
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Net income (loss) |
30,362
|
|
|
|
|
|
|
|
|
| Ending balance (in shares) at Sep. 30, 2024 |
|
|
50,182,233
|
|
|
|
|
|
|
| Ending balance at Sep. 30, 2024 |
13,252
|
|
$ 500
|
103,298
|
(358)
|
(95,657)
|
|
0
|
5,469
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Temporary equity, shares percentage (as a percent) |
|
15.00%
|
|
|
|
|
|
|
|
| Beginning balance (in shares) at Mar. 31, 2024 |
|
|
50,182,233
|
|
|
|
|
|
|
| Beginning balance at Mar. 31, 2024 |
(163,192)
|
|
$ 500
|
106,131
|
(614)
|
(289,645)
|
|
0
|
20,436
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Share-based compensation from issuance of options and compensation-based warrants |
576
|
|
|
576
|
|
|
|
|
|
| Settlement of warrants |
(1,866)
|
|
|
(1,866)
|
|
|
|
|
|
| Settlement of warrants in subsidiary |
(3,023)
|
|
|
11,944
|
|
|
|
|
(14,967)
|
| Series C preferred shares cancelled upon settlement |
|
$ 130,542
|
|
|
|
|
$ 130,542
|
|
|
| Deemed contribution in connection with cancellation of preferred stock to Senior Lenders |
|
$ 5,130
|
|
|
|
|
$ 5,130
|
|
|
| Accretion of 15.00% Series C preferred shares |
(14,318)
|
|
|
(14,318)
|
|
|
|
|
|
| Issuance of warrants |
413
|
|
|
413
|
|
|
|
|
|
| Foreign currency translation adjustment |
(108)
|
|
|
|
(108)
|
|
|
|
|
| Net income (loss) |
134,355
|
|
|
|
|
134,355
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2024 |
|
|
50,182,233
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2024 |
88,509
|
|
$ 500
|
102,880
|
(722)
|
(19,618)
|
|
0
|
5,469
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Temporary equity, shares percentage (as a percent) |
|
15.00%
|
|
|
|
|
|
|
|
| Share-based compensation from issuance of options and compensation-based warrants |
418
|
|
|
418
|
|
|
|
|
|
| Foreign currency translation adjustment |
364
|
|
|
|
364
|
|
|
|
|
| Net income (loss) |
(76,039)
|
|
|
|
|
(76,039)
|
|
|
|
| Ending balance (in shares) at Sep. 30, 2024 |
|
|
50,182,233
|
|
|
|
|
|
|
| Ending balance at Sep. 30, 2024 |
$ 13,252
|
|
$ 500
|
$ 103,298
|
$ (358)
|
$ (95,657)
|
|
$ 0
|
$ 5,469
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Temporary equity, shares percentage (as a percent) |
|
15.00%
|
|
|
|
|
|
|
|